Does the media refer more to OSUR or QDEL?

In the previous week, QuidelOrtho had 8 more articles in the media than OraSure Technologies. MarketBeat recorded 9 mentions for QuidelOrtho and 1 mentions for OraSure Technologies. QuidelOrtho's average media sentiment score of 0.40 beat OraSure Technologies' score of 0.00 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral QuidelOrtho 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CERS or OSUR more profitable?

Cerus has a net margin of -3.06% compared to OraSure Technologies' net margin of -43.70%. Cerus' return on equity of -10.19% beat OraSure Technologies' return on equity. Company Net Margins Return on Equity Return on Assets Cerus -3.06% -10.19% -3.14% OraSure Technologies -43.70% -19.09% -16.26%

Does the media favor CERS or OSUR?

In the previous week, Cerus had 4 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Cerus and 1 mentions for OraSure Technologies. Cerus' average media sentiment score of 0.71 beat OraSure Technologies' score of 0.00 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer OSUR or EMBC?

In the previous week, OraSure Technologies and OraSure Technologies both had 1 articles in the media. OraSure Technologies' average media sentiment score of 0.00 equaled Embecta'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Embecta 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to OSUR or RXST?

In the previous week, RxSight had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for RxSight and 1 mentions for OraSure Technologies. RxSight's average media sentiment score of 1.20 beat OraSure Technologies' score of 0.00 indicating that RxSight is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral RxSight 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

OraSure Technologies (OSUR) Competitors

$3.82 -0.06 (-1.55%)

Closing price 04:00 PM Eastern

Extended Trading

$3.82 0.00 (0.00%)

As of 04:20 PM Eastern

Compare

OSUR vs. QDEL, CERS, SMTI, EMBC, and RXST

Should you buy OraSure Technologies stock or one of its competitors? OraSure Technologies's main competitors and comparable companies include QuidelOrtho (QDEL), Cerus (CERS), Sanara MedTech (SMTI), Embecta (EMBC), and RxSight (RXST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does OraSure Technologies compare to QuidelOrtho?

OraSure Technologies (NASDAQ:OSUR) and QuidelOrtho (NASDAQ:QDEL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

OraSure Technologies presently has a consensus target price of $3.00, indicating a potential downside of 21.47%. QuidelOrtho has a consensus target price of $13.63, indicating a potential downside of 5.97%. Given QuidelOrtho's higher possible upside, analysts plainly believe QuidelOrtho is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

QuidelOrtho has a net margin of -39.20% compared to OraSure Technologies' net margin of -43.70%. QuidelOrtho's return on equity of 4.88% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
QuidelOrtho	-39.20%	4.88%	1.63%

OraSure Technologies has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.Comparatively, QuidelOrtho has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are owned by institutional investors. 4.7% of OraSure Technologies shares are owned by insiders. Comparatively, 1.1% of QuidelOrtho shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

OraSure Technologies has higher earnings, but lower revenue than QuidelOrtho. OraSure Technologies is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$112.41M	2.34	-$68.73M	-$0.69	N/A
QuidelOrtho	$2.73B	0.36	-$1.13B	-$15.41	N/A

In the previous week, QuidelOrtho had 8 more articles in the media than OraSure Technologies. MarketBeat recorded 9 mentions for QuidelOrtho and 1 mentions for OraSure Technologies. QuidelOrtho's average media sentiment score of 0.40 beat OraSure Technologies' score of 0.00 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
QuidelOrtho	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

QuidelOrtho beats OraSure Technologies on 9 of the 14 factors compared between the two stocks.

How does OraSure Technologies compare to Cerus?

Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Cerus has higher revenue and earnings than OraSure Technologies. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerus	$206.13M	2.63	-$15.63M	-$0.03	N/A
OraSure Technologies	$112.41M	2.34	-$68.73M	-$0.69	N/A

Cerus has a net margin of -3.06% compared to OraSure Technologies' net margin of -43.70%. Cerus' return on equity of -10.19% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerus	-3.06%	-10.19%	-3.14%
OraSure Technologies	-43.70%	-19.09%	-16.26%

78.4% of Cerus shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 5.3% of Cerus shares are owned by company insiders. Comparatively, 4.7% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cerus currently has a consensus target price of $4.00, suggesting a potential upside of 48.70%. OraSure Technologies has a consensus target price of $3.00, suggesting a potential downside of 21.47%. Given Cerus' stronger consensus rating and higher probable upside, research analysts plainly believe Cerus is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Cerus has a beta of 1.81, suggesting that its stock price is 81% more volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1, suggesting that its stock price has a similar volatility profile to the broader market.

In the previous week, Cerus had 4 more articles in the media than OraSure Technologies. MarketBeat recorded 5 mentions for Cerus and 1 mentions for OraSure Technologies. Cerus' average media sentiment score of 0.71 beat OraSure Technologies' score of 0.00 indicating that Cerus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cerus	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OraSure Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cerus beats OraSure Technologies on 14 of the 16 factors compared between the two stocks.

How does OraSure Technologies compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and OraSure Technologies (NASDAQ:OSUR) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Sanara MedTech has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market. Comparatively, OraSure Technologies has a beta of 1, suggesting that its stock price has a similar volatility profile to the broader market.

In the previous week, OraSure Technologies had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 1 mentions for OraSure Technologies and 0 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 1.88 beat OraSure Technologies' score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media.

Company	Overall Sentiment
Sanara MedTech	Very Positive
OraSure Technologies	Neutral

Sanara MedTech has higher earnings, but lower revenue than OraSure Technologies. Sanara MedTech is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$109.81M	2.88	-$37.56M	-$3.59	N/A
OraSure Technologies	$112.41M	2.34	-$68.73M	-$0.69	N/A

Sanara MedTech presently has a consensus target price of $35.00, indicating a potential upside of 1.80%. OraSure Technologies has a consensus target price of $3.00, indicating a potential downside of 21.47%. Given Sanara MedTech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Sanara MedTech is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Sanara MedTech has a net margin of -29.15% compared to OraSure Technologies' net margin of -43.70%. Sanara MedTech's return on equity of 29.72% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-29.15%	29.72%	2.84%
OraSure Technologies	-43.70%	-19.09%	-16.26%

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 42.0% of Sanara MedTech shares are held by company insiders. Comparatively, 4.7% of OraSure Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Sanara MedTech beats OraSure Technologies on 10 of the 15 factors compared between the two stocks.

How does OraSure Technologies compare to Embecta?

OraSure Technologies (NASDAQ:OSUR) and Embecta (NASDAQ:EMBC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

OraSure Technologies has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.Comparatively, Embecta has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

OraSure Technologies currently has a consensus price target of $3.00, suggesting a potential downside of 21.47%. Embecta has a consensus price target of $11.00, suggesting a potential upside of 120.44%. Given Embecta's stronger consensus rating and higher possible upside, analysts clearly believe Embecta is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Embecta	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Embecta has a net margin of 8.59% compared to OraSure Technologies' net margin of -43.70%. OraSure Technologies' return on equity of -19.09% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
Embecta	8.59%	-19.25%	10.82%

93.5% of OraSure Technologies shares are owned by institutional investors. Comparatively, 93.8% of Embecta shares are owned by institutional investors. 4.7% of OraSure Technologies shares are owned by insiders. Comparatively, 1.3% of Embecta shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Embecta has higher revenue and earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$112.41M	2.34	-$68.73M	-$0.69	N/A
Embecta	$1.08B	0.26	$95.40M	$1.48	3.37

In the previous week, OraSure Technologies and OraSure Technologies both had 1 articles in the media. OraSure Technologies' average media sentiment score of 0.00 equaled Embecta'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Embecta	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Embecta beats OraSure Technologies on 9 of the 13 factors compared between the two stocks.

How does OraSure Technologies compare to RxSight?

OraSure Technologies (NASDAQ:OSUR) and RxSight (NASDAQ:RXST) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

RxSight has higher revenue and earnings than OraSure Technologies. RxSight is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$112.41M	2.34	-$68.73M	-$0.69	N/A
RxSight	$134.48M	1.94	-$38.94M	-$1.13	N/A

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by insiders. Comparatively, 10.1% of RxSight shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

OraSure Technologies has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, RxSight has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market.

OraSure Technologies currently has a consensus target price of $3.00, indicating a potential downside of 21.47%. RxSight has a consensus target price of $8.37, indicating a potential upside of 33.65%. Given RxSight's stronger consensus rating and higher possible upside, analysts plainly believe RxSight is more favorable than OraSure Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
RxSight	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

RxSight has a net margin of -36.80% compared to OraSure Technologies' net margin of -43.70%. RxSight's return on equity of -17.35% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-43.70%	-19.09%	-16.26%
RxSight	-36.80%	-17.35%	-14.70%

In the previous week, RxSight had 2 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for RxSight and 1 mentions for OraSure Technologies. RxSight's average media sentiment score of 1.20 beat OraSure Technologies' score of 0.00 indicating that RxSight is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
RxSight	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RxSight beats OraSure Technologies on 12 of the 16 factors compared between the two stocks.

Get OraSure Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OSUR vs. The Competition

Export

Metric	OraSure Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$263.46M	$5.84B	$7.29B	$12.71B
Dividend Yield	N/A	1.75%	2.54%	10.79%
P/E Ratio	-5.54	26.16	271.39	24.10
Price / Sales	2.34	69.41	604.58	77.05
Price / Cash	N/A	33.71	29.03	36.90
Price / Book	0.80	6.18	11.18	6.40
Net Income	-$68.73M	$149.30M	$3.46B	$348.28M
7 Day Performance	0.26%	0.89%	1.98%	0.92%
1 Month Performance	-3.78%	8.83%	7.32%	5.10%
1 Year Performance	27.33%	7.23%	24.76%	16.16%

OraSure Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
OSUR OraSure Technologies	0.7778 of 5 stars	$3.82 -1.5%	$3.00 -21.5%	+29.3%	$263.46M	$112.41M	N/A	840
QDEL QuidelOrtho	1.4135 of 5 stars	$13.78 -5.5%	$13.63 -1.1%	-47.2%	$946.95M	$2.73B	N/A	6,500
CERS Cerus	2.05 of 5 stars	$2.91 -1.9%	$4.00 +37.3%	+122.1%	$591.46M	$206.13M	N/A	290
SMTI Sanara MedTech	1.7627 of 5 stars	$34.15 +0.4%	$35.00 +2.5%	+1.5%	$313.72M	$109.81M	N/A	60
EMBC Embecta	2.8882 of 5 stars	$5.19 +1.1%	$11.00 +112.2%	-63.6%	$295.48M	$1.08B	3.52	1,850

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OSUR) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OraSure Technologies (OSUR) Competitors

OSUR vs. QDEL, CERS, SMTI, EMBC, and RXST

How does OraSure Technologies compare to QuidelOrtho?

Summary

How does OraSure Technologies compare to Cerus?

Summary

How does OraSure Technologies compare to Sanara MedTech?

Summary

How does OraSure Technologies compare to Embecta?

Summary

How does OraSure Technologies compare to RxSight?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OraSure Technologies (OSUR) Competitors

OSUR vs. QDEL, CERS, SMTI, EMBC, and RXST

How does OraSure Technologies compare to QuidelOrtho?

Do analysts recommend OSUR or QDEL?

Is OSUR or QDEL more profitable?

Which has more volatility and risk, OSUR or QDEL?

Do institutionals and insiders believe in OSUR or QDEL?

Which has higher earnings & valuation, OSUR or QDEL?

Does the media refer more to OSUR or QDEL?

Summary

How does OraSure Technologies compare to Cerus?

Which has better valuation and earnings, CERS or OSUR?

Is CERS or OSUR more profitable?

Do insiders and institutionals hold more shares of CERS or OSUR?

Do analysts recommend CERS or OSUR?

Which has more volatility & risk, CERS or OSUR?

Does the media favor CERS or OSUR?

Summary

How does OraSure Technologies compare to Sanara MedTech?

Which has more risk and volatility, SMTI or OSUR?

Does the media favor SMTI or OSUR?

Which has preferable earnings and valuation, SMTI or OSUR?

Do analysts recommend SMTI or OSUR?

Is SMTI or OSUR more profitable?

Do institutionals & insiders believe in SMTI or OSUR?

Summary

How does OraSure Technologies compare to Embecta?

Which has more volatility and risk, OSUR or EMBC?

Do analysts prefer OSUR or EMBC?

Is OSUR or EMBC more profitable?

Do institutionals and insiders hold more shares of OSUR or EMBC?

Which has better earnings and valuation, OSUR or EMBC?

Does the media prefer OSUR or EMBC?

Summary

How does OraSure Technologies compare to RxSight?

Which has stronger earnings & valuation, OSUR or RXST?

Do institutionals & insiders hold more shares of OSUR or RXST?

Which has more risk & volatility, OSUR or RXST?

Do analysts rate OSUR or RXST?

Is OSUR or RXST more profitable?

Does the media refer more to OSUR or RXST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OSUR vs. The Competition

OraSure Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools